Skip to main content
. Author manuscript; available in PMC: 2018 Sep 27.
Published in final edited form as: Neurotox Res. 2015 Jul 23;28(4):302–318. doi: 10.1007/s12640-015-9548-6

Fig. 11.

Fig. 11

Effect of D-512 on the combination treatment of 1.56 μM BSO for 24 h followed by 50 μM 6-OHDA for 24 h in restoring cell viability of PC12 cells. PC12 cells were co-treated with different concentrations of D-512 along with 1.56 μM BSO for 24 h followed by treatment with 50 μM 6-OHDA alone for 24 h (a) or co-treatment with D-512 and 50 μM 6-OHDA for 24 h (b). PC12 cells were pretreated with different concentrations of D-512 for 24 h followed by co-treatment with 1.56 μM BSO for 24 h and final treatment with 50 μM 6-OHDA alone for 24 h (c) or co-treatment with D-512 and 50 μM 6-OHDA for 24 h (d). The values shown are the mean ± SD of at least three independent experiments performed with 6–8 replicates. One-way ANOVA analysis followed by Tukey’s multiple comparison post hoc test was performed (***p \ 0.0001, **p \ 0.001, *p \ 0.01, compared to control and ***p \ 0.0001, *p \ 0.01 compared to BSO + 6-OHDA group)